ASND
Ascendis Pharma AS
NASDAQ: ASND · HEALTHCARE · BIOTECHNOLOGY
$249.55
+1.50% today
Updated 2026-10-28
Market cap
$16.01B
P/E ratio
18.65
P/S ratio
15.30x
EPS (TTM)
$13.05
Dividend yield
—
52W range
$188 – $282
Volume
0.7M
Ascendis Pharma AS (ASND) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$249.55
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.3B | $0.4B | $0.7B | $0.8B | $1.0B | $1.2B | $1.4B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 18.65x (capped 25x) · Margin: 70.90%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.